[
  {
    "question": "Patient came with orange retina; what is the Diagnosis:",
    "option_a": "Syphlis",
    "option_b": "Brucellosis",
    "option_c": "Bortenella",
    "option_d": "Malaria",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurocysticercosis is a parasitic infection of the central nervous system caused by the larval form of Taenia solium, the pork tapeworm. Humans acquire cysticercosis by ingesting eggs from contaminated food or water, which then migrate hematogenously to the central nervous system. After ingestion, T. solium eggs hatch in the intestine. The released oncospheres cross the intestinal wall and travel via the bloodstream to lodge in the brain, where they develop into cysts. MRI typically shows cystic lesions with an eccentric nodule (the scolex), sometimes with surrounding edema and ring enhancement during the inflammatory phase. Patients can present with seizures, headaches, focal neurological deficits, or signs of increased intracranial pressure depending on the cysts\u2019 location and number. In HIV patients, the immunocompromised state may alter presentations, but the classic imaging findings remain a key diagnostic clue. Diagnosis is based on neuroimaging (MRI and CT) and serologic testing (such as the enzyme-linked immunoelectrotransfer blot [EITB]). Differential diagnoses include tuberculomas, toxoplasmosis (especially in HIV), brain abscesses, and metastatic lesions. The presence of a cyst with an eccentric scolex is highly specific for neurocysticercosis. The first-line treatment usually involves antiparasitic agents such as Albendazole, often in combination with corticosteroids to reduce the inflammatory response associated with cyst degeneration. Antiepileptic drugs are used for seizure control. In pregnant patients, risks and benefits are carefully weighed; corticosteroids and Albendazole are used cautiously with close monitoring, while in lactating women, drug transfer through breast milk is considered and alternative management strategies might be employed if appropriate. Option A (Tinea solium) is intended to refer to Taenia solium, the correct causative organism. The other options are not provided, making Option A the proper choice by context. 1. The presence of a cyst with an eccentric scolex on MRI is virtually pathognomonic for neurocysticercosis. 2. Neurocysticercosis is a leading cause of acquired epilepsy in endemic regions. 3. Combination therapy with antiparasitic and steroid treatment is crucial to reducing inflammation and symptomatic seizures. Recent research supports shorter courses of antiparasitic therapy combined with corticosteroids to minimize adverse inflammatory responses. Updated guidelines from organizations such as the CDC and WHO continue to endorse Albendazole as the primary treatment, with an emphasis on tailored therapy based on cyst stage and patient immune status.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "TB patient started on treatment then had seizure, what medication causing the seizure:",
    "option_a": "Isoniazide",
    "option_b": "Ethambutol",
    "option_c": "Rifambicine",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurocysticercosis is a parasitic infection of the central nervous system caused by the larval form of Taenia solium, the pork tapeworm. Humans acquire cysticercosis by ingesting eggs from contaminated food or water, which then migrate hematogenously to the central nervous system. After ingestion, T. solium eggs hatch in the intestine. The released oncospheres cross the intestinal wall and travel via the bloodstream to lodge in the brain, where they develop into cysts. MRI typically shows cystic lesions with an eccentric nodule (the scolex), sometimes with surrounding edema and ring enhancement during the inflammatory phase. Patients can present with seizures, headaches, focal neurological deficits, or signs of increased intracranial pressure depending on the cysts\u2019 location and number. In HIV patients, the immunocompromised state may alter presentations, but the classic imaging findings remain a key diagnostic clue. Diagnosis is based on neuroimaging (MRI and CT) and serologic testing (such as the enzyme-linked immunoelectrotransfer blot [EITB]). Differential diagnoses include tuberculomas, toxoplasmosis (especially in HIV), brain abscesses, and metastatic lesions. The presence of a cyst with an eccentric scolex is highly specific for neurocysticercosis. The first-line treatment usually involves antiparasitic agents such as Albendazole, often in combination with corticosteroids to reduce the inflammatory response associated with cyst degeneration. Antiepileptic drugs are used for seizure control. In pregnant patients, risks and benefits are carefully weighed; corticosteroids and Albendazole are used cautiously with close monitoring, while in lactating women, drug transfer through breast milk is considered and alternative management strategies might be employed if appropriate. Option A (Tinea solium) is intended to refer to Taenia solium, the correct causative organism. The other options are not provided, making Option A the proper choice by context. 1. The presence of a cyst with an eccentric scolex on MRI is virtually pathognomonic for neurocysticercosis. 2. Neurocysticercosis is a leading cause of acquired epilepsy in endemic regions. 3. Combination therapy with antiparasitic and steroid treatment is crucial to reducing inflammation and symptomatic seizures. Recent research supports shorter courses of antiparasitic therapy combined with corticosteroids to minimize adverse inflammatory responses. Updated guidelines from organizations such as the CDC and WHO continue to endorse Albendazole as the primary treatment, with an emphasis on tailored therapy based on cyst stage and patient immune status.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "HIV patient non compliant to his medication, MRI showed non enhanced posterior hyperintensities. What is the treatment:",
    "option_a": "HAART",
    "option_b": "Flucanozole",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurocysticercosis is a parasitic infection of the central nervous system caused by the larval form of Taenia solium, the pork tapeworm. Humans acquire cysticercosis by ingesting eggs from contaminated food or water, which then migrate hematogenously to the central nervous system. After ingestion, T. solium eggs hatch in the intestine. The released oncospheres cross the intestinal wall and travel via the bloodstream to lodge in the brain, where they develop into cysts. MRI typically shows cystic lesions with an eccentric nodule (the scolex), sometimes with surrounding edema and ring enhancement during the inflammatory phase. Patients can present with seizures, headaches, focal neurological deficits, or signs of increased intracranial pressure depending on the cysts\u2019 location and number. In HIV patients, the immunocompromised state may alter presentations, but the classic imaging findings remain a key diagnostic clue. Diagnosis is based on neuroimaging (MRI and CT) and serologic testing (such as the enzyme-linked immunoelectrotransfer blot [EITB]). Differential diagnoses include tuberculomas, toxoplasmosis (especially in HIV), brain abscesses, and metastatic lesions. The presence of a cyst with an eccentric scolex is highly specific for neurocysticercosis. The first-line treatment usually involves antiparasitic agents such as Albendazole, often in combination with corticosteroids to reduce the inflammatory response associated with cyst degeneration. Antiepileptic drugs are used for seizure control. In pregnant patients, risks and benefits are carefully weighed; corticosteroids and Albendazole are used cautiously with close monitoring, while in lactating women, drug transfer through breast milk is considered and alternative management strategies might be employed if appropriate. Option A (Tinea solium) is intended to refer to Taenia solium, the correct causative organism. The other options are not provided, making Option A the proper choice by context. 1. The presence of a cyst with an eccentric scolex on MRI is virtually pathognomonic for neurocysticercosis. 2. Neurocysticercosis is a leading cause of acquired epilepsy in endemic regions. 3. Combination therapy with antiparasitic and steroid treatment is crucial to reducing inflammation and symptomatic seizures. Recent research supports shorter courses of antiparasitic therapy combined with corticosteroids to minimize adverse inflammatory responses. Updated guidelines from organizations such as the CDC and WHO continue to endorse Albendazole as the primary treatment, with an emphasis on tailored therapy based on cyst stage and patient immune status.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "HIV patient MRI showed multiple brain abscess, what is the causing organism?",
    "option_a": "fungal",
    "option_b": "Bacterial",
    "option_c": "Parasite",
    "option_d": "Viral",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "In advanced HIV/AIDS patients, brain lesions are often due to opportunistic infections. In particular, reactivation of latent Toxoplasma gondii (a parasite) is the most common cause of multiple ring-enhancing brain abscesses. Toxoplasma gondii is an obligate intracellular parasite that, when reactivated in immunocompromised hosts (especially those with CD4 counts <100 cells/\u00b5L), invades brain tissue. The result is focal necrosis and abscess formation observed on MRI as multiple ring-enhancing lesions, most commonly located in the basal ganglia and corticomedullary junction. Patients typically present with headache, confusion, focal neurological deficits, and sometimes seizures. The radiographic appearance of multiple ring-enhancing lesions in HIV patients prompts strong consideration for toxoplasmosis, with the parasitic etiology being the key underlying process. Differential diagnoses include primary CNS lymphoma (which typically presents as a single lesion or a lesion periventricularly), bacterial abscesses, fungal infections, and other parasites. Diagnosis is supported by seropositivity for Toxoplasma IgG and observation of clinical and radiologic improvement after empiric anti-toxoplasma therapy. First-line treatment involves a combination of pyrimethamine, sulfadiazine, and leucovorin. In pregnant patients, management must consider fetal safety, and spiramycin is often used in early pregnancy to reduce the risk of vertical transmission. For lactating women, treatment with pyrimethamine\u2013sulfadiazine is generally acceptable, but careful monitoring is required to minimize adverse effects. Option A (fungal) and Option B (bacterial) do not typically account for the multiple abscesses observed in HIV, and Option D (viral) is not consistent with abscess formation. Option C (parasite) correctly identifies Toxoplasma gondii as the common etiologic agent in this scenario. 1. In HIV patients with CD4 counts <100, multiple ring-enhancing lesions are most commonly due to toxoplasmosis. 2. Empiric therapy is often initiated, and response to treatment further supports the diagnosis. Recent guidelines and studies underscore the importance of rapid initiation of empiric anti-toxoplasma therapy in immunocompromised patients with characteristic imaging findings, as delays can lead to significant morbidity and mortality.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "pt with hx of neuropsychiatry and dementia for more than 5 year had PrPSc, Dx:",
    "option_a": "variant CJD",
    "option_b": "Kuru",
    "option_c": "familial insomnia",
    "option_d": "familial CJD",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Neuro-infectious",
    "explanation": "Prion diseases are a group of transmissible spongiform encephalopathies characterized by the accumulation of abnormally folded prion proteins (PrPSc) leading to neurodegeneration. They can be sporadic, acquired, or familial in origin. The conversion of normal prion protein (PrPC) to its misfolded form (PrPSc) results in neuronal cell death, vacuolation, and spongiform changes in brain tissue. While most prion diseases are rapidly progressive, familial prion diseases such as familial Creutzfeldt\u2010Jakob Disease (fCJD) can have a more protracted course compared to the typically shorter disease duration seen in Kuru or variant CJD. Although prion diseases generally progress over months, the mention of neuropsychiatric symptoms and dementia persisting for more than 5 years is atypical for acquired forms like Kuru (which usually has a course of about 12 months). This prolonged course is more consistent with a familial prion disease, such as familial CJD. Key differentials include variant CJD (often seen in younger patients with early psychiatric symptoms and a median course of about 14 months), Kuru (associated with cannibalistic practices and a relatively short course), and fatal familial insomnia (characterized by sleep disturbances and autonomic dysfunction). Detailed family history, genetic testing, and brain imaging help differentiate these entities. Currently, there is no disease-modifying treatment available for prion diseases. Management remains supportive and palliative. In pregnant or lactating patients, supportive care is the mainstay since no specific therapies exist and treatment is focused on symptomatic relief. Option A (variant CJD) typically presents with a faster decline; Option B (Kuru) is associated with cannibalistic transmission and has a shorter disease course; Option C (familial insomnia) shows prominent sleep disturbances rather than isolated dementia over many years. Option D (familial CJD) is the best fit for a patient with a prolonged course and a positive PrPSc finding. 1. Familial prion diseases may have a slightly longer course than sporadic or acquired forms despite all being fatal. 2. Detailed family history is crucial in differentiating familial prion diseases from other rapid neurodegenerative conditions. Recent research continues to explore potential anti-prion compounds, although effective therapies remain elusive. Genetic testing and advanced neuroimaging are increasingly used to aid in diagnosis, with current management focused on supportive care.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient came with neurosyphilis, VDRL +ve; what is the symptoms associated with the disease:",
    "option_a": "erythema nodusum",
    "option_b": "hypomelatonic macule",
    "option_c": "constricted pupils",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurosyphilis is a manifestation of tertiary syphilis that involves the central nervous system. A hallmark clinical sign is the Argyll Robertson pupil, which reflects midbrain involvement. Treponema pallidum infection leads to chronic inflammation of the central nervous system. In neurosyphilis, the damage to the midbrain can cause the characteristic small, irregular, and constricted pupils, which accommodate but do not react to light (Argyll Robertson pupil). Patients with neurosyphilis may present with a variety of neurologic deficits including cognitive impairment, ataxia, and sensory disturbances. The presence of constricted, irregular pupils that demonstrate light-near dissociation is highly suggestive of neurosyphilis in the appropriate clinical context. Differential diagnoses include diabetic neuropathy affecting the pupils, midbrain lesions from other etiologies, and other infectious or inflammatory processes. Confirmation is typically by positive serologic tests (VDRL, RPR) and CSF analysis demonstrating elevated protein with lymphocytic pleocytosis. The treatment of choice is intravenous penicillin G. In pregnant patients, penicillin remains the standard due to its proven safety profile in preventing congenital syphilis. Lactating mothers can also be safely treated with penicillin. Option A (erythema nodosum) and Option B (hypomelatonic macule) are not typical manifestations of neurosyphilis. Option C (constricted pupils) accurately reflects the Argyll Robertson pupil seen in this condition, thereby making it the correct answer. 1. Argyll Robertson pupil is pathognomonic for neurosyphilis and is characterized by small, irregular pupils that accommodate but do not react to light. 2. Positive VDRL along with neurological symptoms should prompt evaluation for neurosyphilis. Modern guidelines continue to recommend IV penicillin G as the treatment for neurosyphilis, highlighting the need for early diagnosis to prevent irreversible neurological damage.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "DM patient came to ER with black lesion in her nostril; what is the treatment?",
    "option_a": "Amphotricine",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "In diabetic patients, a black necrotic lesion in the nasal region is highly suspicious for mucormycosis, an invasive fungal infection that requires urgent management. Mucormycosis is caused by fungi of the Mucorales order. These organisms are angioinvasive, leading to vascular thrombosis, ischemia, and tissue necrosis. Poorly controlled diabetes, particularly when associated with diabetic ketoacidosis, creates a favorable acidic environment for the growth of these fungi. The clinical presentation of a black lesion in the nostril indicates tissue necrosis, which is characteristic of rhino-orbital-cerebral mucormycosis. This condition is a medical emergency as the infection can rapidly spread to the orbit and brain, leading to high morbidity and mortality. Differential diagnoses include invasive aspergillosis and other causes of necrotizing infections of the nasal cavity. Definitive diagnosis is usually made with a combination of imaging studies (CT/MRI) and histopathological examination showing broad, non-septate hyphae with right-angle branching. The first-line treatment for mucormycosis is high-dose intravenous Liposomal Amphotericin B. Aggressive surgical debridement of necrotic tissue is also a critical component of management. For patients who are pregnant or lactating, Amphotericin B is considered the treatment of choice due to its Category B status and relatively safe profile compared to other antifungals. Option A (Amphotericin) is correct as it constitutes the backbone of therapy for invasive mucormycosis. The other options, although not listed, would not take precedence over amphotericin in this emergency scenario. 1. In diabetics presenting with black necrotic lesions in the nasal area, always suspect mucormycosis and act promptly. 2. Combined medical (Liposomal Amphotericin B) and surgical interventions are essential to improve survival outcomes. Recent studies emphasize the importance of early diagnosis and prompt combined therapy with Liposomal Amphotericin B and surgical debridement in reducing mortality in mucormycosis, reinforcing its role as the standard of care even in special populations such as pregnant and lactating women.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with typical hx of CJD, family wanted him to be in organ donation program; what is the best action?",
    "option_a": "Allow only for liver transplant",
    "option_b": "remove them from organ donation program",
    "option_c": "Allow the patient to be in the organ donation program",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Creutzfeldt-Jakob Disease (CJD) is a rapidly progressive neurodegenerative disorder caused by prions, which are misfolded proteins that can induce similar misfolding in normal proteins. Its transmissible nature raises concerns regarding the safety of tissue transplantation, including organ donation. Prions cause neuronal loss, spongiform changes, and gliosis without initiating a conventional inflammatory response. Their resistance to standard sterilization procedures makes them particularly dangerous in a transplant context, as even small amounts of infected tissue could potentially transmit the disease to recipients. Patients with CJD typically present with rapidly progressive dementia, myoclonus, ataxia, and visual disturbances. Because the disease is invariably fatal and highly infectious through contaminated tissues, any procedure involving transplantation must be scrutinized. Diagnosis is generally supported by a combination of clinical findings, MRI brain imaging (often showing hyperintensities in the basal ganglia or cortical ribboning), EEG with periodic sharp wave complexes, and CSF markers (like 14-3-3 protein). Differential diagnoses include rapidly progressive dementias such as autoimmune encephalitis or atypical Alzheimer\u2019s disease, but the characteristic features in CJD help distinguish it. Currently, there is no effective treatment or cure for CJD; management is supportive. From a public health standpoint, guidelines universally recommend excluding patients with CJD from organ donation programs to prevent the iatrogenic transmission of prions. In settings involving potential organ donation, strict regulatory guidelines must be followed. Although pregnancy and lactation issues are not directly applicable here, surgical and transplantation guidelines consistently emphasize extreme caution with prion diseases. Option A (Allow only for liver transplant) is incorrect because the risk of prion transmission is not organ-specific. Option B (Remove them from organ donation program) is correct and aligns with guidelines that prevent prion transmission. Option C (Allow the patient to be in the organ donation program) is incorrect due to the severe transmission risk. 1) CJD is a prion disease with no cure, making early diagnosis essential but primarily for supportive management. 2) Organ donation from individuals with CJD is contraindicated due to the risk of prion transmission. 3) Standard sterilization techniques are ineffective against prions. Recent guidelines and research continue to support the exclusion of CJD patients from organ donation programs. There is an ongoing emphasis on strict infection control measures in surgical and transplant settings to mitigate the rare but serious risk of prion transmission.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient has bilateral facial weakness and LP showed high WBC; pic showed Erythema migrans. What is the treatment?",
    "option_a": "Ceftriaxon",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Lyme disease is an infectious disease caused by the spirochete Borrelia burgdorferi, transmitted by tick bites. Erythema migrans, the characteristic rash, is an early hallmark of the infection, and neurologic involvement can occur as part of disseminated disease. After the initial tick bite, Borrelia burgdorferi can disseminate hematogenously, leading to neuroborreliosis. The organism may invade the central nervous system, provoking an inflammatory response that results in lymphocytic pleocytosis in the CSF and cranial neuropathies such as bilateral facial palsy. The presence of bilateral facial weakness, particularly in the context of a high white blood cell count in the CSF, is a recognized manifestation of Lyme neuroborreliosis. The identification of erythema migrans further supports the diagnosis. Diagnostic evaluation includes a detailed history, examination for erythema migrans, and laboratory work-up such as CSF analysis revealing lymphocytic pleocytosis. Serologic tests (ELISA followed by Western blot) are also standard. Differential diagnoses include Bell\u2019s palsy and other causes of facial nerve weakness, but the combination of rash, CSF findings, and bilateral involvement strongly indicates Lyme disease. For Lyme neuroborreliosis, first-line treatment is typically intravenous ceftriaxone for 14 to 28 days. Ceftriaxone is considered safe in pregnancy (Category B) and during lactation, making it an appropriate choice for patients who are pregnant or breastfeeding. Alternatives, like high-dose oral doxycycline, are usually avoided in pregnancy due to contraindications. Option A (Ceftriaxone) is correct as it is the standard treatment for Lyme neuroborreliosis. Other options (B, C, D) are not provided or applicable in this case. 1) Lyme neuroborreliosis often presents with bilateral facial palsy and CSF lymphocytic pleocytosis. 2) Erythema migrans is highly suggestive of Lyme disease when present. 3) IV ceftriaxone remains the treatment of choice for neurologic involvement. Recent studies and updated guidelines continue to endorse IV ceftriaxone as the treatment of choice for neurologic manifestations of Lyme disease, particularly when evidence of CNS involvement exists, ensuring both effective microbial clearance and safety in special populations including pregnant and lactating patients.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with Whipple disease, confirmation",
    "option_a": "less than 5",
    "option_b": "5 to < 10",
    "option_c": "Jejuanal biopsy",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "Whipple disease is a rare, multisystem, infectious disorder caused by the bacterium Tropheryma whipplei. It predominantly affects the gastrointestinal tract but can have systemic implications including joint and neurological involvement. The infection leads to infiltration of the intestinal mucosa by foamy macrophages that contain PAS-positive granules, reflecting the accumulation of bacteria. This phenomenon is central to the disease\u2019s pathology, resulting in malabsorption and systemic symptoms. Clinically, patients may present with weight loss, diarrhea, abdominal pain, arthralgias, and occasionally neurological symptoms. The presence of malabsorption symptoms alongside systemic signs should prompt consideration of Whipple disease. The definitive diagnosis is established by a small intestine biopsy, typically from the duodenum or jejunum, showing PAS-positive macrophages. Differential diagnoses include other causes of malabsorption such as celiac disease, inflammatory bowel disease, or infections, but the PAS stain is characteristic for Whipple disease. Initial treatment involves intravenous antibiotics, typically ceftriaxone, for 2\u20134 weeks, followed by a prolonged course (1\u20132 years) of oral trimethoprim-sulfamethoxazole (TMP-SMX). It is critical to monitor for treatment response due to high relapse rates. In pregnancy, the use of TMP-SMX is usually avoided in the first trimester because of teratogenic risks, so alternative regimens may be considered. Lactating patients require similar considerations to minimize infant exposure. Option C (Jejunal biopsy) is correct because histological confirmation via a small bowel biopsy that demonstrates PAS-positive macrophages is the gold standard for diagnosing Whipple disease. Options A and B, which contain numerical values without context, are not relevant. 1) PAS-positive staining in small bowel biopsies is pathognomonic for Whipple disease. 2) Whipple disease can mimic other malabsorptive conditions, making biopsy essential for diagnosis. 3) Prolonged antibiotic treatment is crucial due to the risk of relapse. Current research supports the use of early IV antibiotics followed by long-term oral therapy to reduce relapse rates. Advances in PCR testing have improved diagnostic accuracy, though histopathologic confirmation remains the standard.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "Most common route of spread for epidural abscess",
    "option_a": "Hematogenous",
    "option_b": "Direct",
    "option_c": "Osteomyltitis",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "An epidural abscess is a collection of pus between the dura mater and the vertebral column. It is a serious infection that can lead to compression of neural structures and requires prompt diagnosis and management. The most common mechanism is hematogenous spread, where bacteria from a distant infection seed the epidural space. Other mechanisms include direct extension from adjacent infections (such as osteomyelitis) or iatrogenic causes following invasive procedures, but hematogenous dissemination remains the predominant route. Patients typically present with back pain, fever, and neurological deficits depending on the level of the abscess. Risk factors include diabetes, intravenous drug use, and recent invasive procedures. A high index of suspicion is warranted when patients with these risk factors present with spinal pain and systemic signs of infection. MRI with contrast is the imaging modality of choice for diagnosing an epidural abscess. Differential diagnoses include disk herniation, vertebral osteomyelitis, and spinal metastases. Laboratory studies (e.g., elevated ESR, CRP, and leukocytosis) help support the diagnosis. The standard management involves prompt initiation of broad-spectrum intravenous antibiotics tailored to culture results, typically covering Staphylococcus aureus. Surgical decompression is indicated in cases with neurological deficits or failure of medical management. In pregnant patients, antibiotic selection should consider fetal safety, with agents like vancomycin and ceftriaxone being commonly used and considered relatively safe. Lactating patients should be counseled on the minimal risk associated with these antibiotics, but monitoring is advised. Option A (Hematogenous) is correct because the majority of epidural abscesses result from bacteria spreading through the bloodstream from a remote focus, rather than by direct extension or contiguous osteomyelitis, although these can also be causes in less common scenarios. 1) Early diagnosis of spinal epidural abscess is critical to prevent permanent neurological damage. 2) Back pain with systemic signs of infection in at-risk populations should prompt evaluation for epidural abscess. 3) Hematogenous spread is the most common route in these infections. Recent guidelines underscore the importance of early identification via MRI and the initiation of aggressive antibiotic therapy combined with surgical intervention when indicated. Updated protocols also recommend careful consideration of antibiotic regimens in special populations, such as pregnant or lactating patients, to ensure safety while effectively treating the infection.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "Indian with seizures and multiple small brain lesions",
    "option_a": "Cytsocircosis",
    "option_b": "Toxoplasmosis",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurocysticercosis is the most common parasitic infestation of the central nervous system worldwide and is particularly prevalent in endemic regions like India. It occurs when humans ingest eggs of Taenia solium, which develop into larvae (cysticerci) and lodge in the brain, often presenting with seizures. After ingestion of T. solium eggs, the oncospheres penetrate the intestinal mucosa and disseminate hematogenously to the brain. There they form cysts in various stages. The host\u2019s inflammatory response to cyst degeneration leads to edema and gliosis, triggering seizure activity. Current evidence emphasizes the importance of the cyst location (parenchymal vs. extraparenchymal) and the stage of the cyst (vesicular, colloidal, granular nodular, calcific) in determining clinical manifestations. Patients typically present with new-onset seizures, focal neurological deficits, or signs of increased intracranial pressure. In endemic regions such as India, neurocysticercosis is the leading cause of acquired epilepsy. Multiple small brain lesions seen on imaging (CT/MRI) may display a scolex, providing a radiologic clue to the diagnosis. Differential diagnoses include cerebral toxoplasmosis (more common in immunocompromised individuals), tuberculomas, brain abscesses, and metastases. The diagnosis is made based on neuroimaging (CT/MRI showing cystic lesions with or without a scolex), epidemiologic exposure, and serological tests (e.g., enzyme-linked immunoelectrotransfer blot). First-line management includes antiparasitic therapy (most commonly albendazole, sometimes combined with praziquantel) plus corticosteroids to attenuate the inflammatory response. Antiepileptic drugs are prescribed for seizure control. In pregnant or lactating patients, the risks and benefits of antiparasitic therapy must be weighed carefully; typically, treatment is deferred in the first trimester if possible and managed on a case-by-case basis with multidisciplinary input. Recent guidelines also stress the importance of supportive care and monitoring for potential complications. Option A ('Cytsocircosis') is intended to denote cysticercosis, which fits the clinical scenario perfectly. Option B (Toxoplasmosis) is more commonly associated with multiple ring-enhancing lesions in immunocompromised patients (especially those with HIV) rather than in immunocompetent Indian patients presenting with seizures. 1) Always consider neurocysticercosis in patients from endemic regions presenting with new-onset seizures. 2) Identification of a scolex on neuroimaging is pathognomonic. 3) Management requires a combination approach with antiparasitic agents, steroids, and antiepileptics. Recent studies support the use of albendazole (15 mg/kg/day in divided doses for 8-28 days) combined with corticosteroids (e.g., dexamethasone or prednisolone) to reduce treatment-related cerebral edema. Updated protocols recommend individualized treatment plans based on the cyst location, number, and stage.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "A patient diagnosed with meningococcal meningitis, the family asks about prevention or disease transmission",
    "option_a": "No risk after 2 days of isolation",
    "option_b": "Ciprofloxacin",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Meningococcal meningitis, caused by Neisseria meningitidis, is a medical emergency with rapid progression and high morbidity. Due to the organism's high transmissibility via respiratory droplets, prophylaxis for close contacts is essential to prevent secondary cases. N. meningitidis colonizes the nasopharynx and can invade the bloodstream leading to meningitis and septicemia. Transmission occurs via close or prolonged contact. The bacterium's polysaccharide capsule helps evade the immune response, making prophylactic measures crucial for exposed individuals. Patients present with high fever, headache, neck stiffness, and altered mental status. The risk of secondary transmission among household and close contacts is significant, which necessitates early prophylaxis even before the pathogen has completed its full transmission cycle. Differential diagnoses of bacterial meningitis include Streptococcus pneumoniae and Haemophilus influenzae. Confirmation is typically achieved through lumbar puncture with CSF analysis and culture. In the context of an outbreak or confirmed case, epidemiologic links guide prophylaxis decisions. For prophylaxis, the first-line options include a single dose of ciprofloxacin (typically 500 mg orally in adults), rifampin for 2 days, or a single dose of intramuscular ceftriaxone. For pregnant or lactating women, ciprofloxacin is generally avoided due to potential risks; ceftriaxone is preferred because of its safety profile in these populations. Immediate chemoprophylaxis for close contacts is recommended by current CDC and WHO guidelines. Option A ('No risk after 2 days of isolation') is incorrect because transmission can occur before isolation and prophylaxis should be administered to all close contacts regardless of isolation duration. Option B ('Ciprofloxacin') is correct for the prophylaxis of adult contacts in non-pregnant patients, aligning with current guidelines. 1) Prompt prophylaxis for close contacts can drastically reduce secondary transmission of meningococcal meningitis. 2) Always consider alternative prophylactic agents in pregnancy (e.g., ceftriaxone). 3) Vaccination campaigns are crucial during meningococcal outbreaks. Recent guidelines from the CDC and WHO continue to endorse ciprofloxacin as a cost-effective, single-dose prophylactic agent for adults while advising alternative regimens for pregnant patients due to safety concerns. Ongoing studies aim to optimize prophylaxis strategies in different exposure scenarios.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "?? year-old female was brought by her family for the complaint of progressive decline in school performance and abnormal behavior in the last 3 months. After that, her condition worsened and she became unresponsive. EEG showed periodic bursts. EEG showed high voltage waves ?? Which of the following is the most likely diagnosis?",
    "option_a": "Creutzfeldt-Jakob disease (CJD)",
    "option_b": "Subacute sclerosis panencephalitis (SSPE)",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Subacute sclerosing panencephalitis (SSPE) is a rare, progressive, and invariably fatal complication of measles infection. It typically presents several years after an initial measles infection, primarily affecting children and adolescents. SSPE results from a persistent, mutant measles virus that evades the immune response and causes chronic inflammation and widespread demyelination of the brain. This slow viral encephalitis progressively disrupts cortical and subcortical function, leading to cognitive decline and motor disturbances. Patients with SSPE often exhibit a gradual decline in cognitive function and academic performance, behavioral changes, and myoclonic jerks. The classic EEG finding is periodic, high-voltage discharges (often described as stereotyped, rhythmic complexes), similar to but distinct from the periodic sharp waves seen in Creutzfeldt-Jakob disease. The reference to a decline in 'school performance' aligns with the typical presentation in school-age children. Differentials include Creutzfeldt-Jakob disease (CJD), which also shows periodic EEG complexes but typically affects older individuals and progresses rapidly, as well as other neurodegenerative or metabolic encephalopathies. Diagnosis of SSPE is supported by clinical history (including previous measles infection), characteristic EEG patterns, elevated measles antibody titers in the CSF, and neuroimaging findings. There is no definitive cure for SSPE. Management is primarily supportive, with some regimens including antiviral agents (e.g., intraventricular interferon-alpha), immunomodulatory therapies, or antiepileptics to manage myoclonic jerks. In pregnancy and lactation, treatment options are extremely limited and focus on supportive care, with careful risk-benefit analysis given the potential teratogenicity of some agents. Option A (Creutzfeldt-Jakob disease) is less likely given the patient\u2019s age and the history of declining school performance rather than a rapidly progressive dementia typical of CJD. Option B (SSPE) aligns closely with the described clinical features of gradual cognitive and behavioral decline with characteristic periodic bursts on EEG. 1) A history of measles infection is a key risk factor for SSPE. 2) The EEG in SSPE often shows a characteristic periodic pattern that helps differentiate it from other encephalopathies. 3) Measles vaccination is the most effective preventive measure against SSPE. Recent literature emphasizes the continued lack of definitive treatment for SSPE, underscoring prevention through measles vaccination as the best strategy. Research is ongoing into antiviral and immunomodulatory therapies, but no consensus has emerged regarding their effectiveness.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "HIV with CD4 count of 5, Viral load in thousands developed parkinsonism with basal ganglia involvement;",
    "option_a": "Toxoplasmosis",
    "option_b": "Cryptococcus",
    "option_c": "Lymphoma",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "In patients with advanced HIV/AIDS (CD4 count very low), opportunistic infections are common. Toxoplasmosis, caused by Toxoplasma gondii, frequently targets the brain and is the most common cause of brain abscesses in such patients. When lesions affect the basal ganglia, patients may develop movement disorders, including parkinsonism. Toxoplasma gondii enters the brain and forms abscesses or ring-enhancing lesions predominantly in the basal ganglia and corticomedullary junction. In the setting of severe immunosuppression (CD4 count <100, and especially as low as 5), inadequate immune surveillance allows unchecked parasite proliferation, leading to focal inflammation and disruption of basal ganglia circuitry. The clinical presentation often includes focal neurological deficits, altered mental status, and, in cases of basal ganglia involvement, movement disorders such as parkinsonism. Neuroimaging (CT/MRI) typically reveals multiple ring-enhancing lesions. Although primary CNS lymphoma is a consideration, it usually presents as a solitary lesion and is less likely to cause parkinsonism. Differentials include primary CNS lymphoma, progressive multifocal leukoencephalopathy (PML), and HIV-related encephalopathy. Toxoplasma encephalitis is suggested by neuroimaging (multiple ring-enhancing lesions), clinical presentation, and serologic testing. In some cases, a trial of anti-toxoplasmosis therapy is used diagnostically. The first-line treatment is a combination of pyrimethamine, sulfadiazine, and folinic acid (leucovorin). Therapy is usually continued for at least 6 weeks, with maintenance dosing to prevent relapse until immune reconstitution occurs. In pregnancy, pyrimethamine is contraindicated in the first trimester due to teratogenic effects; alternatives such as spiramycin or adjusted regimens may be considered, and consultation with an infectious disease specialist is recommended. Lactating women should be evaluated carefully for drug transfer through breast milk and potential adverse effects. Option A (Toxoplasmosis) is the most appropriate given the patient\u2019s severe immunosuppression and typical involvement of the basal ganglia, which can manifest as parkinsonian symptoms. Option B (Cryptococcus) usually causes meningitis rather than focal basal ganglia lesions. Option C (Lymphoma) generally presents as a solitary lesion and does not classically lead to parkinsonism. 1) In HIV patients with a CD4 count below 100, always consider cerebral toxoplasmosis when multiple ring-enhancing lesions are present. 2) Basal ganglia involvement may cause movement disorders like parkinsonism. 3) Early initiation of therapy can significantly improve neurological outcomes. Recent guidelines from infectious disease societies continue to endorse the pyrimethamine-sulfadiazine regimen for cerebral toxoplasmosis, with modifications as needed for pregnancy and drug tolerability. Ongoing research is aimed at optimizing treatment duration and improving outcomes in patients with severe immunosuppression.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "Schistosoma Mansonia, the most common presentation",
    "option_a": "Venous thrombosis",
    "option_b": "Intracranial Anyrsum",
    "option_c": "Focal deficit",
    "option_d": "Mylopathy",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Neuro-infectious",
    "explanation": "Schistosomiasis is a parasitic infection caused by blood flukes. When Schistosoma mansoni invades the central nervous system, it most commonly manifests as spinal cord involvement (neuroschistosomiasis), leading to myelopathy. This process results from the deposition of eggs in the spinal cord tissue, provoking a granulomatous inflammatory reaction. Egg deposition in the spinal cord triggers an immune-mediated inflammatory response. The resulting granulomas and fibrosis lead to demyelination and the formation of vacuoles, causing a classical picture of myelopathy. This inflammatory process can interrupt normal neuronal conduction, particularly in the thoracolumbar regions. Patients typically present with progressive lower limb weakness, sensory deficits, spasticity, and bladder or bowel dysfunction. The clinical syndrome is best explained by inflammation of the spinal cord and adjacent nerve roots, rather than isolated vascular or focal cortical problems. Diagnosis usually involves a high index of suspicion in endemic areas, supported by MRI findings (showing intramedullary hyperintensity or lesions), cerebrospinal fluid analysis (which may reveal eosinophils), and serologic tests for schistosomiasis. Differential diagnoses include transverse myelitis from other etiologies, spinal cord tumors, and demyelinating diseases. First-line management includes antiparasitic therapy with praziquantel, coupled with corticosteroids to mitigate the inflammatory response. In pregnant or lactating patients, praziquantel is considered acceptable under current guidelines (generally classified as Category B), but a risk\u2013benefit analysis is prudent. Second-line or adjunct therapies may be considered if there is an inadequate response to initial treatment. Option A (Venous thrombosis) and Option B (Intracranial aneurysm) are not typical presentations of neuroschistosomiasis. Option C (Focal deficit) is too nonspecific. Option D (Mylopathy) correctly identifies the most common neurological presentation seen in spinal schistosomiasis. 1. Schistosoma mansoni-associated neuroschistosomiasis most frequently presents with spinal cord involvement rather than cerebral manifestations. 2. Early recognition and treatment with praziquantel and steroids can improve neurological outcomes. Recent studies and WHO guidelines support the combined use of praziquantel and corticosteroids in neuroschistosomiasis. Advances in MRI imaging have further improved early detection and management, leading to better prognoses when therapy is initiated promptly.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "The HIV patient came with a 1-month history of bilateral LE weakness and numbness. No back pain what is the pathogenesis? and developed spinal cord disease in one month; what is the pathophysiology?",
    "option_a": "Vacuolar myelopathy",
    "option_b": "HTLV-1",
    "option_c": "Radiculomyelopathy",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "HIV-associated vacuolar myelopathy is a recognized complication in patients with advanced HIV/AIDS. It primarily affects the spinal cord\u2019s white matter, leading to a myelopathy characterized by bilateral lower extremity motor and sensory deficits. The condition is attributed to direct or indirect effects of HIV infection on the spinal cord. Inflammatory processes, including microglial activation and astrocytic injury, result in vacuole formation within the myelin. This demyelination particularly affects the lateral and dorsal columns, impairing neural conduction. Typically, patients present with a subacute, symmetric spastic paraparesis, decreased proprioception, and sensory deficits in the lower limbs, usually without significant back pain. These features differentiate it from compressive myelopathies or radiculopathies, which often present with pain. Diagnosis is based on clinical findings supported by imaging such as MRI, which may show subtle changes in the spinal cord white matter. CSF analysis and exclusion of other opportunistic infections are integral. Differential diagnoses include compressive myelopathies (e.g., due to tumor or abscess), HTLV-1 associated myelopathy, and other inflammatory spinal cord diseases. The cornerstone of management is optimization of antiretroviral therapy (ART), which can help stabilize or improve neurological function. There is currently no specific therapy targeted solely at vacuolar myelopathy. In pregnant or lactating patients, continuing effective and safe ART is essential with careful monitoring of both maternal and fetal health. Option A (Vacuolar myelopathy) is the correct answer, given its established association with HIV. Option B (HTLV-1) causes a similar myelopathy but is less likely in the context of HIV without epidemiologic evidence. Option C (Radiculomyelopathy) generally involves nerve roots with radicular pain, which is not typical in this patient\u2019s presentation, and Option D is not provided. 1. HIV-associated vacuolar myelopathy often presents insidiously without back pain. 2. Maintaining effective ART is crucial in preventing neurological complications in HIV patients. Recent research emphasizes the role of early and sustained antiretroviral therapy in reducing the incidence and progression of HIV-associated neurological complications, including vacuolar myelopathy. Improved imaging techniques have also aided in early detection and differentiation from other myelopathies.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "Patient from Sudan presented with fluctuating high fever, AMS, anemia etc what do",
    "option_a": "ceftrixone + Vancomycine",
    "option_b": "Anti-Malaria ( the name of the actual drug)",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Malaria remains a significant cause of morbidity and mortality in endemic regions like Sudan. Patients often present with cyclical fevers, altered mental status (AMS), and anemia, all of which are characteristic of severe malaria, particularly due to Plasmodium falciparum. Plasmodium falciparum infects red blood cells, leading to cycles of rupture and hemolysis. The resultant inflammatory response and microvascular occlusions can lead to cerebral malaria (manifested as AMS) and severe anemia from hemolysis and splenic clearance. Fluctuating fevers are a hallmark of the parasite\u2019s life cycle. The patient\u2019s presentation with fluctuating high fever, AMS, and anemia is strongly suggestive of malaria rather than a primary bacterial infection. While bacterial meningitis could present with AMS and fever, the presence of anemia and the epidemiologic context (Sudan) lean more towards malaria. Diagnosis is typically confirmed by peripheral blood smear (both thick and thin films) to identify malarial parasites, or by using rapid diagnostic tests (RDTs). Differential diagnoses include bacterial meningitis (which would typically also present with neck stiffness and other meningeal signs) and other tropical infections (like typhoid fever). For severe malaria, the current first-line treatment is intravenous artesunate. In uncomplicated cases, oral artemisinin-based combination therapy (ACT) such as artemether-lumefantrine is recommended. In pregnant patients, particularly in the second and third trimesters, intravenous artesunate is also recommended for severe malaria because of its superior safety profile compared to quinine, while in the first trimester, the risk-benefit ratio must be carefully weighed. Lactating mothers can safely receive artesunate-based therapies. Option A (ceftriaxone + vancomycin) is appropriate for bacterial meningitis but does not cover malaria. Option B (Anti-Malaria therapy) is correct, as the clinical picture aligns with malaria. Options C and D are either missing or not specified, confirming that the intended answer is anti-malarial therapy. 1. In malaria-endemic regions, always consider malaria in the differential for fever, AMS, and anemia. 2. Early recognition and treatment of severe malaria with IV artesunate can be life-saving. The latest WHO guidelines endorse intravenous artesunate as the treatment of choice for severe malaria. Recent studies have also highlighted the importance of rapid diagnostic testing and partner therapies in reducing malaria-related mortality, especially among vulnerable populations such as pregnant women.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "question": "What should be done to decrease risk of post herpetic neuralgia?",
    "option_a": "Anti-viral medication",
    "option_b": "Gabapentin",
    "option_c": "IV lidocaine",
    "option_d": "? (Another analgesia)",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Postherpetic neuralgia (PHN) is a common, debilitating complication of herpes zoster (shingles), which results from the reactivation of the varicella zoster virus. Early antiviral intervention is known to reduce viral replication and nerve damage. During reactivation, VZV replicates in sensory ganglia causing inflammation and neuronal injury. Without timely intervention, this can lead to long-lasting neuropathic pain, as the damaged nerves send aberrant pain signals, resulting in PHN. Patients with herpes zoster initially present with a painful, unilateral vesicular rash. If the viral replication is not promptly controlled, they may develop persistent pain in the affected dermatome even after the rash resolves, termed PHN. The diagnosis of herpes zoster is primarily clinical, based on the characteristic rash and distribution. Differential diagnoses include other causes of neuropathic pain, such as diabetic neuropathy or trigeminal neuralgia. Laboratory confirmation by PCR can be used in atypical cases. First-line management to decrease the risk of PHN is the initiation of antiviral therapy (such as acyclovir, valacyclovir, or famciclovir) within 72 hours of rash onset. Adjunct measures for pain control, like gabapentin, are typically reserved for managing established PHN rather than for prophylaxis. In pregnant or lactating patients, acyclovir is generally considered safe and is recommended when indicated. Option A (Anti-viral medication) is correct because timely antiviral treatment reduces viral replication and nerve damage, thereby lowering the risk of PHN. Option B (Gabapentin) is helpful for managing established PHN pain but does not prevent its occurrence. Option C (IV lidocaine) is not part of prophylactic treatment and is used as an intervention for refractory neuropathic pain. Option D is unspecified, making Option A the best choice. 1. Early initiation of antiviral therapy (ideally within 72 hours of rash onset) is crucial to reduce the incidence of PHN. 2. While gabapentin and other neuropathic agents are effective for managing PHN pain, they do not prevent its development. Recent clinical trials and meta-analyses support the role of early antiviral treatment in reducing PHN risk. Updated guidelines from infectious disease and neurology societies continue to recommend this approach, and studies have confirmed the safety of acyclovir in pregnant and lactating populations when clinically indicated.",
    "exam_year": "2024",
    "exam_type": "Part II"
  },
  {
    "question": "Patient was found to have tuberculosis, started on medication and later developed seizure, what is the cause?",
    "option_a": "Isoniazid",
    "option_b": "Ethambutol",
    "option_c": "Rifampin",
    "option_d": "? (Another anti- TB medication)",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Isoniazid is a first\u2010line anti\u2010tuberculosis medication that is well known for its neurotoxic side effects, which can include seizures and peripheral neuropathy, particularly when doses are high or when pyridoxine (vitamin B6) is not adequately supplemented. Isoniazid interferes with pyridoxine metabolism by inhibiting the enzyme pyridoxine phosphokinase. This leads to a deficiency of pyridoxal 5'-phosphate, the active form of vitamin B6, which is essential for synthesizing GABA (an inhibitory neurotransmitter). Reduced GABA levels can lead to neuronal hyperexcitability and seizures. In a patient on TB therapy presenting with new-onset seizures, isoniazid toxicity should be highly suspected, especially if pyridoxine supplementation is inadequate. This adverse effect is dose related and can occur even at therapeutic doses in susceptible individuals. The diagnosis is largely clinical. History of recent isoniazid administration, timing of symptom onset, and exclusion of other causes of seizures are pivotal. Differential diagnoses might include metabolic derangements (e.g., hypoglycemia, electrolyte imbalances), other drug toxicities, or CNS infections. Blood levels of isoniazid can be determined in cases of suspected overdose. First-line management involves supportive care and the rapid administration of intravenous pyridoxine. The generally recommended dose is equal to the estimated amount of ingested isoniazid. In a standard therapeutic setting, prophylactic pyridoxine is recommended, especially in high-risk patients (e.g., malnourished, pregnant or lactating women) where pyridoxine deficiency may be more pronounced. The treatment guidelines apply similarly during pregnancy and lactation with consideration of fetal/neonatal safety. Option A (Isoniazid) is correct because its known adverse effects include neurotoxicity and seizures induced by pyridoxine deficiency. Option B (Ethambutol) is primarily associated with optic neuritis, not seizures. Option C (Rifampin) has its own toxicity profile (hepatotoxicity, gastrointestinal upset) but is not typically linked to seizures. The fourth option is not specified, but no other common anti-TB drug has as direct a seizure association as isoniazid. 1. Always co-administer pyridoxine with isoniazid in TB treatment, especially in populations at risk for deficiency. 2. Isoniazid toxicity can present even in therapeutic dosing if prophylaxis with pyridoxine is omitted. 3. Early recognition of drug-induced seizures can improve patient outcomes. Recent guidelines emphasize routine pyridoxine supplementation with isoniazid therapy to prevent neurotoxic side effects. Studies continue to support the efficacy of pyridoxine in mitigating isoniazid-induced seizures, and updated TB management protocols now include specific dosing recommendations for vulnerable populations including pregnant and lactating women.",
    "exam_year": "2024",
    "exam_type": "Part II"
  }
]